Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence

por Christopoulou, Athina, Ardavanis, Alexandros, Papandreou, Christos, Koumakis, Georgios, Papatsimpas, Georgios, Papakotoulas, Pavlos, Tsoukalas, Nikolaos, Andreadis, Charalambos, Samelis, Georgios, Papakostas, Pavlos, Aravantinos, Gerasimos, Ziras, Nikolaos, Souggleri, Maria, Kalofonos, Charalambos, Samantas, Epameinondas, Makrantonakis, Paris, Pentheroudakis, Georgios, Athanasiadis, Athanasios, Stergiou, Helen, Bokas, Alexandros, Grivas, Anastasios, Tripodaki, Elli-Sofia, Varthalitis, Ioannis, Timotheadou, Eleni, Boukovinas, Ioannis
Publicado 2022

Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?

por Tsoukalas, Nikolaos, Papakotoulas, Pavlos, Christopoulou, Athina, Ardavanis, Alexandros, Koumakis, Georgios, Papandreou, Christos, Papatsimpas, Georgios, Papakostas, Pavlos, Samelis, Georgios, Andreadis, Charalambos, Aravantinos, Gerasimos, Ziras, Nikolaos, Kalofonos, Charalambos, Samantas, Epameinondas, Souggleri, Maria, Makrantonakis, Paris, Pentheroudakis, Georgios, Athanasiadis, Athanasios, Stergiou, Helen, Tripodaki, Elli-Sofia, Bokas, Alexandros, Grivas, Anastasios, Timotheadou, Eleni, Bournakis, Evangelos, Varthalitis, Ioannis, Boukovinas, Ioannis
Publicado 2020